Activation of the RhoA/ROCK pathway has also been implicated in the pathogenesis of ALS, although studied to a lesser degree and focusing on the disease-modifying effects of ROCK inhibition. The gene discussed is RHOA; the disease is amyotrophic lateral sclerosis.